INITIAL INVESTIGATIONAL NEW DRUG APPLICATION

early phase, nonclinical. ... Reference to this information is appropriate because the new intended use does not involve targeting a new anatomical implantation site and therefore would not likely negatively affect the ability of the study device to access the implantation site. ... - Monitoring of subjects for signs and symptoms of allergic ... ................
................